Sarepta Therapeutics, Inc.

Q3 2016 vs. Q2 2018 13F Holders

Period
Q3 2016
Q2 2018
Num holders
247
361
Total reported value, excl. options
$2.61 B
$8.05 B
Total shares, excl. options
42,447,712
60,885,130
Manager Q3 2016
Shares 		Q2 2018
Shares 		Diff Chg %